Corvus Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Based In South San Franciscocaliforniathe Company Is Dedicated To Developing Innovative Therapies For Immune Diseases And Cancerit Is Publicly Traded On The Nasdaq Under The Ticker Symbol Crvs The Company Specializes In Itk Inhibitiona Unique Method To Modulate The Immune Systemits Lead Productsoquelitinibis A First In Class Oral Therapy That Selectively Inhibits Itk And Is Currently Undergoing Clinical Trials For Conditions Such As Atopic Dermatitis And Peripheral T Cell Lymphomaptcl Corvus Is Also Advancing Therapies That Target The Adenosine Pathwayincluding Ciforadenanta Small Molecule Antagonistand Mupadolimabcpi 006 An Anti Cd73 Antibodymupadolimab Has Completed Phase 1 Studies And Is Being Evaluated In Non Small Cell Lung Cancer In Collaboration With Angel Pharmaceuticals Corvus Pharmaceuticals Is Committed To Advancing Its Clinical Pipeline Through Strategic Trials And Emphasizes The Importance Of Its Scientific Approach In Addressing Various Immune And Cancer Related Conditions
